Jihan Madani, Carmen Yea, Areej Mahjoub, Paula Brna, Kevin Jones, Giulia Longoni, Maryam Nabavi Nouri, Tamer Rizk, Wendy A Stewart, Colin Wilbur, E Ann Yeh
AIM: To characterize the presenting features and outcomes in children with seronegative autoimmune encephalitis, and to evaluate whether scores at nadir for the Modified Rankin Scale (mRS) and Clinical Assessment Scale for Autoimmune Encephalitis (CASE) or its paediatric-specific modification (ped-CASE) are predictive of outcomes. METHOD: This observational study included children younger than 18 years of age with seronegative autoimmune encephalitis. Demographics and clinical data were collected...
March 15, 2024: Developmental Medicine and Child Neurology